摘要
目的观察甲基化CpG结合蛋白2(MeCP2)在帕金森病细胞模型中的表达。方法采用免疫荧光技术、Westernblot检测MeCP2、酪氨酸羟化酶(TH)蛋白在帕金森病细胞模型中表达的变化。结果在正常SH.SY5Y细胞中有MeCP2、TH表达,而在帕金森病细胞模型中,免疫荧光检测结果显示MeCP2、TH的表达降低,Westernblot结果进一步证实MeCP2、TH的表达下降,MeCP2/β-肌动蛋白(β—actin)由(86.97±4.62)%下降至(22.19±2.85)%,TH/β—actin南(49.92±2.35)%下降至(9.02±0.84)%。结论MeCP2在帕金森病的发病过程中起重要作用,MeCP2可能参与了帕金森病的发病过程。
Objective To investigate the regularity of methyl-CpG-binding protein 2 (MeCP2) expression in cell model of Parkinson' s disease. Methods Detected the expression of MeCP2 and tyrosine hydroxylase (TH) in cell model of Parkinson' s disease by immunofluorescence and Western blotting. Results We found the MeCP2/TH protein expression in SH-SYSY cell by immunofluorescence and Western blotting, and also the MeCP2 protein and TH protein expression reduced in the cell model of Parkinson' s disease. The expression of MeCP2 protein and TH protein reduced were further confirmed by Western blotting analysis, the ratio of MeCP2/β-actin from (86. 97 ± 4. 62) % decreased to (22. 19 ± 2. 85 ) %, and the ratio of TH/13-actin from (49.92 ± 2.35 ) % decreased to (9. 02 ± 0. 84) %. Conclusion MeCP2 plays an important role in the pathogenesis of Parkinson' s disease, MeCP2 may be involved in the pathogenesis of Parkinson' s disease.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2014年第5期1033-1035,共3页
Chinese Journal of Experimental Surgery
基金
湖北省荆门市科技计划资助项目(2013S01)